 | • レポートコード：MRC2303H065 • 出版社/出版日：360iResearch / 2022年10月11日 • レポート形態：英語、PDF、222ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の当調査レポートでは、2021年に400.8億ドルであった世界の患者モニタリングデバイス市場規模が2022年に453.1億ドルとなり、今後は年平均13.14％成長して2027年までに841.0億ドルに達すると予測しています。当書は、患者モニタリングデバイスの世界市場について調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別（血糖モニタリングシステム、心臓モニタリングデバイス、胎児＆新生児モニタリングデバイス、血行動態/血圧モニタリングデバイス、マルチパラメータモニタリングデバイス）分析、エンドユーザー別（外来手術センター、在宅医療、病院）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報など、以下の構成でまとめております。なお、当書には、100 Plus、Abbott Laboratories、BIOTRONIK SE & Co. KG、Boston Scientific Corporation、Cardiomo, Inc.、ChroniSense Medical, Ltd.、Compumedics Limited、Dexcom, Inc.、Drägerwerk AG & Co. KGaA、Edwards Lifesciences Corporationなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の患者モニタリングデバイス市場規模：製品別 - 血糖モニタリングシステムの市場規模 - 心臓モニタリングデバイスの市場規模 - 胎児＆新生児モニタリングデバイスの市場規模 - 血行動態/血圧モニタリングデバイスの市場規模 - マルチパラメータモニタリングデバイスの市場規模 ・世界の患者モニタリングデバイス市場規模：エンドユーザー別 - 外来手術センターにおける市場規模 - 在宅医療における市場規模 - 病院における市場規模 ・世界の患者モニタリングデバイス市場規模：地域別 - 南北アメリカの患者モニタリングデバイス市場規模 アメリカの患者モニタリングデバイス市場規模 カナダの患者モニタリングデバイス市場規模 ブラジルの患者モニタリングデバイス市場規模 ... - アジア太平洋の患者モニタリングデバイス市場規模 日本の患者モニタリングデバイス市場規模 中国の患者モニタリングデバイス市場規模 インドの患者モニタリングデバイス市場規模 韓国の患者モニタリングデバイス市場規模 台湾の患者モニタリングデバイス市場規模 ... - ヨーロッパ/中東/アフリカの患者モニタリングデバイス市場規模 イギリスの患者モニタリングデバイス市場規模 ドイツの患者モニタリングデバイス市場規模 フランスの患者モニタリングデバイス市場規模 ロシアの患者モニタリングデバイス市場規模 ... - その他地域の患者モニタリングデバイス市場規模 ・競争状況 ・企業情報 |
The Global Patient Monitoring Devices Market size was estimated at USD 40.08 billion in 2021 and expected to reach USD 45.31 billion in 2022, and is projected to grow at a CAGR 13.14% to reach USD 84.10 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Patient Monitoring Devices to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Blood Glucose Monitoring Systems, Cardiac Monitoring Devices, Fetal & Neonatal Monitoring Devices, Hemodynamic/Pressure Monitoring Devices, Multi-parameter Monitoring Devices, Neuromonitoring Devices, Respiratory Monitoring Devices, Temperature Monitoring Devices, and Weight Monitoring Devices. The Blood Glucose Monitoring Systems is further studied across Continuous Glucose Monitoring Systems and Self-monitoring Blood Glucose Systems. The Cardiac Monitoring Devices is further studied across ECG Devices, Event Monitors, Implantable Loop Recorders, Mobile Cardiac Telemetry Monitors, and Smart/Wearable ECG Monitors. The Fetal & Neonatal Monitoring Devices is further studied across Fetal Monitoring Devices and Neonatal Monitoring Devices. The Hemodynamic/Pressure Monitoring Devices is further studied across Blood Pressure Monitors, Disposables, and Hemodynamic Monitors. The Multi-parameter Monitoring Devices is further studied across High-acuity Monitoring Devices, Low-acuity Monitoring Devices, and Mid-acuity Monitoring Devices. The Neuromonitoring Devices is further studied across Cerebral Oximeters, Electroencephalograph Machines, Electromyography Machines, Intracranial Pressure Monitors, Magnetoencephalography Machines, and Transcranial Doppler Machines. The Respiratory Monitoring Devices is further studied across Capnographs, Peak Flow Meters, Pulse Oximeters, and Spirometers. The Temperature Monitoring Devices is further studied across Handheld Temperature Monitoring Devices, Invasive Temperature Monitoring Devices, Smart Temperature Monitoring Devices, Table-top Temperature Monitoring Devices, and Wearable Continuous Monitoring Devices. The Weight Monitoring Devices is further studied across Analog and Digital.
Based on End User, the market was studied across Ambulatory Surgery Centers, Home Care Settings, and Hospitals.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Patient Monitoring Devices market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Patient Monitoring Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Patient Monitoring Devices Market, including 100 Plus, Abbott Laboratories, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Cardiomo, Inc., ChroniSense Medical, Ltd., Compumedics Limited, Dexcom, Inc., Drägerwerk AG & Co. KGaA, Edwards Lifesciences Corporation, GE Healthcare, Getinge AB, Hill-Rom Holdings, Inc., Koninklijke Philips N.V., Masimo Corporation, Medtronic PLC, Mindray Medical International Limited, Natus Medical, Nihon Kohden Corporation, Nonin Medical, Inc., Omron Corporation, and Schiller AG.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Patient Monitoring Devices Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Patient Monitoring Devices Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Patient Monitoring Devices Market?
4. What is the competitive strategic window for opportunities in the Global Patient Monitoring Devices Market?
5. What are the technology trends and regulatory frameworks in the Global Patient Monitoring Devices Market?
6. What is the market share of the leading vendors in the Global Patient Monitoring Devices Market?
7. What modes and strategic moves are considered suitable for entering the Global Patient Monitoring Devices Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Technological Advancement in Patient Monitoring Devices & Availability of Wireless Monitoring Devices
5.1.1.2. Rising Prevalence of Chronic Diseases
5.1.1.3. Increasing Preference for Wearable Patient Monitoring Devices, Biosensors, and Smart Implants among Healthcare Payers
5.1.2. Restraints
5.1.2.1. Risks Associated with Invasive Monitoring Devices
5.1.2.2. Relative High Cost of Patient Monitoring Products and Inadequate Reimbursement
5.1.3. Opportunities
5.1.3.1. Growing Market for Non-Invasive and Minimally Invasive Devices
5.1.3.2. Increasing Demand for Patient Monitoring Devices in Non-Hospital Settings
5.1.4. Challenges
5.1.4.1. Lack of Skilled Healthcare Professionals
5.1.4.2. Increasing Pricing Pressure on Market Players
5.2. Cumulative Impact of COVID-19
6. Patient Monitoring Devices Market, by Product
6.1. Introduction
6.2. Blood Glucose Monitoring Systems
6.3.1. Continuous Glucose Monitoring Systems
6.3.2. Self-monitoring Blood Glucose Systems
6.3. Cardiac Monitoring Devices
6.4.1. ECG Devices
6.4.2. Event Monitors
6.4.3. Implantable Loop Recorders
6.4.4. Mobile Cardiac Telemetry Monitors
6.4.5. Smart/Wearable ECG Monitors
6.4. Fetal & Neonatal Monitoring Devices
6.5.1. Fetal Monitoring Devices
6.5.2. Neonatal Monitoring Devices
6.5. Hemodynamic/Pressure Monitoring Devices
6.6.1. Blood Pressure Monitors
6.6.2. Disposables
6.6.3. Hemodynamic Monitors
6.6. Multi-parameter Monitoring Devices
6.7.1. High-acuity Monitoring Devices
6.7.2. Low-acuity Monitoring Devices
6.7.3. Mid-acuity Monitoring Devices
6.7. Neuromonitoring Devices
6.8.1. Cerebral Oximeters
6.8.2. Electroencephalograph Machines
6.8.3. Electromyography Machines
6.8.4. Intracranial Pressure Monitors
6.8.5. Magnetoencephalography Machines
6.8.6. Transcranial Doppler Machines
6.8. Respiratory Monitoring Devices
6.9.1. Capnographs
6.9.2. Peak Flow Meters
6.9.3. Pulse Oximeters
6.9.4. Spirometers
6.9. Temperature Monitoring Devices
6.10.1. Handheld Temperature Monitoring Devices
6.10.2. Invasive Temperature Monitoring Devices
6.10.3. Smart Temperature Monitoring Devices
6.10.4. Table-top Temperature Monitoring Devices
6.10.5. Wearable Continuous Monitoring Devices
6.10. Weight Monitoring Devices
6.11.1. Analog
6.11.2. Digital
7. Patient Monitoring Devices Market, by End User
7.1. Introduction
7.2. Ambulatory Surgery Centers
7.3. Home Care Settings
7.4. Hospitals
8. Americas Patient Monitoring Devices Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Patient Monitoring Devices Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Patient Monitoring Devices Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. 100 Plus
12.1.1. Business Overview
12.1.2. Key Executives
12.1.3. Product & Services
12.2. Abbott Laboratories
12.2.1. Business Overview
12.2.2. Key Executives
12.2.3. Product & Services
12.3. BIOTRONIK SE & Co. KG
12.3.1. Business Overview
12.3.2. Key Executives
12.3.3. Product & Services
12.4. Boston Scientific Corporation
12.4.1. Business Overview
12.4.2. Key Executives
12.4.3. Product & Services
12.5. Cardiomo, Inc.
12.5.1. Business Overview
12.5.2. Key Executives
12.5.3. Product & Services
12.6. ChroniSense Medical, Ltd.
12.6.1. Business Overview
12.6.2. Key Executives
12.6.3. Product & Services
12.7. Compumedics Limited
12.7.1. Business Overview
12.7.2. Key Executives
12.7.3. Product & Services
12.8. Dexcom, Inc.
12.8.1. Business Overview
12.8.2. Key Executives
12.8.3. Product & Services
12.9. Drägerwerk AG & Co. KGaA
12.9.1. Business Overview
12.9.2. Key Executives
12.9.3. Product & Services
12.10. Edwards Lifesciences Corporation
12.10.1. Business Overview
12.10.2. Key Executives
12.10.3. Product & Services
12.11. GE Healthcare
12.11.1. Business Overview
12.11.2. Key Executives
12.11.3. Product & Services
12.12. Getinge AB
12.12.1. Business Overview
12.12.2. Key Executives
12.12.3. Product & Services
12.13. Hill-Rom Holdings, Inc.
12.13.1. Business Overview
12.13.2. Key Executives
12.13.3. Product & Services
12.14. Koninklijke Philips N.V.
12.14.1. Business Overview
12.14.2. Key Executives
12.14.3. Product & Services
12.15. Masimo Corporation
12.15.1. Business Overview
12.15.2. Key Executives
12.15.3. Product & Services
12.16. Medtronic PLC
12.16.1. Business Overview
12.16.2. Key Executives
12.16.3. Product & Services
12.17. Mindray Medical International Limited
12.17.1. Business Overview
12.17.2. Key Executives
12.17.3. Product & Services
12.18. Natus Medical
12.18.1. Business Overview
12.18.2. Key Executives
12.18.3. Product & Services
12.19. Nihon Kohden Corporation
12.19.1. Business Overview
12.19.2. Key Executives
12.19.3. Product & Services
12.20. Nonin Medical, Inc.
12.20.1. Business Overview
12.20.2. Key Executives
12.20.3. Product & Services
12.21. Omron Corporation
12.21.1. Business Overview
12.21.2. Key Executives
12.21.3. Product & Services
12.22. Schiller AG
12.22.1. Business Overview
12.22.2. Key Executives
12.22.3. Product & Services
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing